<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04312698</url>
  </required_header>
  <id_info>
    <org_study_id>A83_03DL/HT1903</org_study_id>
    <nct_id>NCT04312698</nct_id>
  </id_info>
  <brief_title>Clinical Trial to Evaluate the Efficacy and Safety of CKD-386</brief_title>
  <official_title>A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase III Trial to Evaluate the Efficacy and Safety of D013, D326 and D337 Combination Therapy in Dyslipidemia Patients With Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chong Kun Dang Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chong Kun Dang Pharmaceutical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical Trial to Evaluate the Efficacy and Safety of CKD-386
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 29, 2019</start_date>
  <completion_date type="Anticipated">September 29, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 29, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change rate from baseline in LDL-C</measure>
    <time_frame>8 weeks after drug administrations</time_frame>
    <description>Compare experimental group 1 with comparator group 1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in MSSBP</measure>
    <time_frame>8 weeks after drug administrations</time_frame>
    <description>Compare experimental group 1 with comparator group 2</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">99</enrollment>
  <condition>Dyslipidemia Patients With Hypertension</condition>
  <arm_group>
    <arm_group_label>Experimental Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator Group 1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator Group 2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>D013, D326, D337</intervention_name>
    <description>Experimental: Group 1 Patients assigned to this group are treated with D013, D326, D337</description>
    <arm_group_label>Experimental Group 1</arm_group_label>
    <other_name>Drugs are consist of antihypertensive agent and antihyperlipidemic agent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo of D013, D326, D337</intervention_name>
    <description>Placebo Comparator: Group 1 Patients assigned to this group are treated with D326, D337, placebo of D013</description>
    <arm_group_label>Comparator Group 1</arm_group_label>
    <other_name>Drugs are consist of antihypertensive agent and antihyperlipidemic agent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>D013, placebo of D326, placebo of D337</intervention_name>
    <description>Placebo Comparator: Group 2 Patients assigned to this group are treated with D013, placebo of D326, placebo of D337</description>
    <arm_group_label>Comparator Group 2</arm_group_label>
    <other_name>Drugs are consist of antihypertensive agent and antihyperlipidemic agent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects are diagnosed with Dyslipidemia Patients with Hypertension or are being
             administered anti-hypertension and anti-hypertension drugs after diagnosis.

          2. Subjects who agreed to participate in this clinical trial voluntarily.

        Exclusion Criteria:

          1. Subjects who were satisfied specific blood pressure levels that measured at screening
             period.

          2. Subjects who were satisfied specific lipid levels that measured at screening period.

          3. Subjects who cannot participate in a clinical trial based on the PI's judgment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yeonhwa Park</last_name>
    <phone>82-2-0673-0636</phone>
    <email>yeonhwa@ckdpharm.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Catholic University of Korea Bucheon St. Mary's Hospital</name>
      <address>
        <city>Bucheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang Hyen Ihm</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chungbuk national university hospital</name>
      <address>
        <city>Cheongju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ju Hee Lee</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chungnam national university hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae Hyeong Park</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Inje university Ilsan Paik hospital</name>
      <address>
        <city>Ilsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joon Hyung Doh</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gachon University Gil Medical Center</name>
      <address>
        <city>Incheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Woong Chol Kang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pusan national university hospital</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung Hyun Choi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Korea university Anam hospital</name>
      <address>
        <city>Seongdong</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soon Jun Hong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul metropolitan government Seoul national university Boramae medical center</name>
      <address>
        <city>Seongdong</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae Bin Seo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul national university Bundang hospital</name>
      <address>
        <city>Seongnam-si</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung Won Suh</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kangbuk Samsung hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong Young Lee</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Korea universiy Guro hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin Won Kim</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kyung Hee university hospital at Gangdong</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Il Suk Sohn</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kyung Hee university hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong Shin Woo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yonsei University Medical Center Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seok Min Kang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wonju severance christian hospital</name>
      <address>
        <city>Wonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung Woo Son</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 12, 2020</study_first_submitted>
  <study_first_submitted_qc>March 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2020</study_first_posted>
  <last_update_submitted>March 16, 2020</last_update_submitted>
  <last_update_submitted_qc>March 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypolipidemic Agents</mesh_term>
    <mesh_term>Antihypertensive Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

